FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough
The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term
The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
Clearance marks major shift beyond chemotherapy
No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Subscribe To Our Newsletter & Stay Updated